Company: DVAX
Filing Date: 2025-05-13
Form Type: 8-K
Source: 0001029142-25-000081
Chunk: 0

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-05-13
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 8, 2025, the Board of Directors of Dynavax Technologies Corporation (the “ Company”) appointed Joseph Metzinger as the Company’s Vice President, Chief Accounting Officer, effective as of May 12, 2025 (the “ Effective Date”). In this role, Mr. Metzinger will serve as the Company’s principal accounting officer. Kelly MacDonald, the Company’s Senior Vice President, Chief Financial Officer, will continue to serve as the Company’s principal financial officer.

Mr. Metzinger, age 41, is a seasoned financial executive with 19 years of leadership experience. Since 2024, he has served as a consultant to the Company, supporting its finance and accounting department. From 2022 to 2024, Mr. Metzinger was employed by CFGI, a global accounting and business advisory firm, where he served as a Chief Accounting Officer and controller for a publicly traded biotechnology company. From 2020 to 2022, he served as Chief Accounting Officer of ACC Consumer Finance, a start-up consumer lending company. Prior to 2020, Mr. Metzinger held senior financial leadership roles at both private and publicly held companies, including serving as Chief Accounting Officer for two public entities. He began his career at PricewaterhouseCoopers LLP, where he served as a Manager in the Financial Services practice. Mr. Metzinger is a Certified Public Accountant (Pennsylvania, inactive) and holds a Bachelor of Science degree in Accounting from The Pennsylvania State University.

In connection with his appointment as the Company’s Vice President, Chief Accounting Officer, the Company and Mr. Metzinger entered into an offer letter (the “ Offer Letter”), pursuant to which Mr. Metzinger will receive an annual base salary of $315,000 and is eligible to receive an annual discretionary performance bonus of up to 40% of his then-current base salary. On the Effective Date, Mr. Metzinger will be granted an award of 38,182 restricted stock units and 31,500 stock options pursuant to the Company’s 2018 Equity Incentive Plan, each of which will vest over three years and be fully vest upon the third anniversary following their grant date, subject to Mr. Metzinger’s continuous service with the Company through each applicable vesting date. The Company intends to enter into its standard